Key messages
Download
1 / 12

Key messages - PowerPoint PPT Presentation


  • 132 Views
  • Uploaded on

Key messages. Stephen S Lim, et al. Lancet 2007; 370: 2054-62. Countries that account for 80% of global chronic disease deaths in low-income and middle-income countries. Stephen S Lim, et al. Lancet 2007; 370: 2054-62. Main model parameters. Stephen S Lim, et al. Lancet 2007; 370: 2054-62.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Key messages' - aida


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Key messages

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Countries that account for 80% of global chronic disease deaths in low-income and middle-income countries

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Main model parameters deaths in low-income and middle-income countries

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Example of an absolute risk chart using age, sex, smoking status, systolic blood pressure, and

body-mass index

*Numbers are 10-year risk of fatal ischaemic heart disease or cardiovascular events in Mexico

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Patterns of scale-up of a multidrug regimen for patients at high risk of cardiovascular disease by Commission on Macroeconomics in Health (CMH) category, expressed as a proportion of those accessing health services

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Effects of diff erent individual drugs, measured high risk of cardiovascular disease by Commission on Macroeconomics in Health (CMH) category, expressed as a proportion of those accessing health servicesas relative risk, on fatal and non-fatal ischaemic heart disease and cerebrovascular disease

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Patient cost parameters high risk of cardiovascular disease by Commission on Macroeconomics in Health (CMH) category, expressed as a proportion of those accessing health services

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Cumulative thousands of deaths averted high risk of cardiovascular disease by Commission on Macroeconomics in Health (CMH) category, expressed as a proportion of those accessing health serviceswith a multidrug regimen for the prevention of cardiovascular disease by sex, 2006-15

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Person-years of treatment and number of high risk of cardiovascular disease by Commission on Macroeconomics in Health (CMH) category, expressed as a proportion of those accessing health servicesdeaths averted by age and sex, 2006-15

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Cumulative financial cost of scaling up a high risk of cardiovascular disease by Commission on Macroeconomics in Health (CMH) category, expressed as a proportion of those accessing health servicesmultidrug regimen for the prevention of cardiovascular disease, 2006-15

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Average yearly cost (US$ per head) of scaling high risk of cardiovascular disease by Commission on Macroeconomics in Health (CMH) category, expressed as a proportion of those accessing health servicesup a multidrug regimen for the prevention of

cardiovascular disease by country, 2006-15

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


Average yearly cost (proportion of current health expenditure) of scaling up a multidrug regimen for the prevention of cardiovascular disease by country, 2006-15

Stephen S Lim, et al. Lancet 2007; 370: 2054-62


ad